Tekla Life Sciences Stock Price Prediction

HQL Stock  USD 13.83  0.47  3.29%   
As of now, The relative strength index (RSI) of Tekla Life's share price is at 58. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Tekla Life, making its price go up or down.

Oversold Vs Overbought

58

 
Oversold
 
Overbought
The successful prediction of Tekla Life's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Tekla Life and does not consider all of the tangible or intangible factors available from Tekla Life's fundamental data. We analyze noise-free headlines and recent hype associated with Tekla Life Sciences, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Tekla Life's stock price prediction:
Quarterly Earnings Growth
0.425
Quarterly Revenue Growth
0.07
Using Tekla Life hype-based prediction, you can estimate the value of Tekla Life Sciences from the perspective of Tekla Life response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Tekla Life to buy its stock at a price that has no basis in reality. In that case, they are not buying Tekla because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Tekla Life after-hype prediction price

    
  USD 13.83  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Tekla Life Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
9.9711.2015.21
Details
Naive
Forecast
LowNextHigh
12.1113.3414.58
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13.7914.6815.57
Details

Tekla Life After-Hype Price Prediction Density Analysis

As far as predicting the price of Tekla Life at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tekla Life or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tekla Life, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Tekla Life Estimiated After-Hype Price Volatility

In the context of predicting Tekla Life's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tekla Life's historical news coverage. Tekla Life's after-hype downside and upside margins for the prediction period are 12.60 and 15.06, respectively. We have considered Tekla Life's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
13.83
13.83
After-hype Price
15.06
Upside
Tekla Life is not too volatile at this time. Analysis and calculation of next after-hype price of Tekla Life Sciences is based on 3 months time horizon.

Tekla Life Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Tekla Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tekla Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tekla Life, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.15 
1.23
 0.00  
  0.01 
1 Events / Month
6 Events / Month
Very soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
13.83
13.83
0.00 
4,100  
Notes

Tekla Life Hype Timeline

On the 22nd of November Tekla Life Sciences is traded for 13.83. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Tekla is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.15%. %. The volatility of related hype on Tekla Life is about 1716.28%, with the expected price after the next announcement by competition of 13.82. About 35.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Life Sciences last dividend was issued on the 21st of November 2024. Considering the 90-day investment horizon the next projected press release will be very soon.
Check out Tekla Life Basic Forecasting Models to cross-verify your projections.

Tekla Life Related Hype Analysis

Having access to credible news sources related to Tekla Life's direct competition is more important than ever and may enhance your ability to predict Tekla Life's future price movements. Getting to know how Tekla Life's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tekla Life may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
THWTekla World Healthcare(0.03)4 per month 0.00 (0.26) 0.84 (1.53) 4.33 
THQTekla Healthcare Opportunities(0.27)1 per month 0.00 (0.19) 1.37 (1.65) 5.20 
RVTRoyce Value Closed 0.1 4 per month 0.96  0.02  2.18 (1.59) 8.39 
BTOJohn Hancock Financial(0.24)4 per month 0.72  0.14  2.02 (1.32) 9.88 
HQHTekla Healthcare Investors 0.12 1 per month 0.00 (0.23) 1.31 (1.75) 6.45 
DFPFlaherty and Crumrine(0.36)3 per month 0.42 (0.12) 0.92 (0.76) 2.28 
UTFCohen And Steers 0.05 2 per month 0.70  0.01  1.31 (1.44) 3.41 
ETGEaton Vance Tax(0.33)3 per month 0.83 (0.09) 1.15 (1.30) 3.62 
MYDBlackrock Muniyield(0.02)3 per month 0.55 (0.15) 1.08 (1.06) 2.65 
EVTEaton Vance Tax(0.08)1 per month 0.44 (0.01) 0.97 (0.86) 3.38 
ETBEaton Vance Tax(0.03)2 per month 0.34  0.01  0.92 (0.95) 2.42 
NXCNuveen California Select(0.09)4 per month 0.00 (0.23) 0.94 (0.94) 2.82 
RNPCohen Steers Reit 0.08 2 per month 1.01 (0.05) 1.87 (1.78) 4.83 
XFLTXAI Octagon Floating 0.01 10 per month 0.00 (0.15) 0.45 (0.45) 1.19 
JPINuveen Preferred and(0.09)1 per month 0.48 (0.01) 1.10 (1.04) 3.08 
FPFFirst Trust Intermediate(0.01)2 per month 0.50 (0.15) 0.78 (0.78) 2.53 
FFCFlaherty Crumrine Preferred(0.11)2 per month 0.61 (0.13) 1.17 (0.99) 3.02 
ETJEaton Vance Risk 0.01 2 per month 0.49 (0.06) 1.10 (0.87) 3.37 

Tekla Life Additional Predictive Modules

Most predictive techniques to examine Tekla price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tekla using various technical indicators. When you analyze Tekla charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Tekla Life Predictive Indicators

The successful prediction of Tekla Life stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Tekla Life Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Tekla Life based on analysis of Tekla Life hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Tekla Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tekla Life's related companies.
 2023 2024 (projected)
Dividend Payout Ratio1.8E-41.71E-4
Days Of Payables Outstanding301.91219.7

Story Coverage note for Tekla Life

The number of cover stories for Tekla Life depends on current market conditions and Tekla Life's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tekla Life is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tekla Life's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Tekla Life Short Properties

Tekla Life's future price predictability will typically decrease when Tekla Life's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tekla Life Sciences often depends not only on the future outlook of the potential Tekla Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tekla Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding26.8 M
Cash And Short Term Investments15.2 M
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out Tekla Life Basic Forecasting Models to cross-verify your projections.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.425
Dividend Share
1.3
Earnings Share
1.34
Revenue Per Share
0.134
Quarterly Revenue Growth
0.07
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.